In the rapidly advancing world of veterinary medicine, GS-441524 has emerged as a true game-changer—especially in the treatment of feline infectious peritonitis (FIP), a once invariably fatal disease in cats. For veterinary pharmaceutical developers and compounding pharmacies in the UAE, this breakthrough compound represents more than a therapeutic opportunity—it’s a call to lead the next generation of antiviral veterinary care.

At MedicaPharma, we supply premium-quality GS-441524 API, sourced from GMPcompliant facilities, backed by full documentation and tailored to meet the needs of the UAE’s veterinary and pharmaceutical sectors. If you’re looking to compound innovative, high-purity formulations that meet both clinical and regulatory demands, you’ve found your ideal partner.

Download GMP-Certified API Product List

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations. Click here to download our complete API product list.

“Medicapharma’s products and services are exclusively available to licensed companies and professionals. We do not sell to individuals or private consumers.”

The Power of GS-441524 in FIP Treatment

Feline infectious peritonitis is caused by a mutation of feline coronavirus (FCoV), triggering an aggressive and often fatal immune-mediated response. Traditional veterinary medicine has offered little more than supportive care—until the arrival of GS-441524, a nucleoside analog and the active metabolite of remdesivir.

GS-441524 works by inhibiting viral RNA replication, interrupting the viral life cycle and allowing the immune system to recover. Numerous studies and real-world veterinary applications have shown promising success rates—particularly when the compound is administered in the early stages of the disease. Its favourable safety profile and stable pharmacokinetics make it ideally suited for veterinary compounding into oral, injectable, or capsule forms, depending on the treatment protocol.

This is not a finished medication—it is a raw active ingredient, intended for use by licensed professionals. When compounded responsibly, GS-441524 offers a clear path forward in the management of FIP.

FIP in the UAE: Growing Need for Targeted Therapies

The UAE’s veterinary landscape is transforming. With rising rates of pet ownership, especially of pedigree and indoor cats, there is a corresponding increase in demand for advanced veterinary treatments. Clinics across Dubai, Abu Dhabi, and Sharjah are diagnosing FIP more frequently, and owners are actively seeking treatment options that offer real hope.

However, the success of FIP treatment depends heavily on one key factor: access to high-quality, consistent GS-441524 API—something MedicaPharma delivers without compromise.

Why UAE Buyers Trust MedicaPharma

At MedicaPharma, we don’t just supply ingredients. We deliver confidence, consistency, and compliance. Our GS-441524 API is specifically selected for veterinary pharmaceutical development and compounding use. It meets the highest standards of purity and quality, and every batch is supported by a comprehensive documentation package including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and TSE/BSE declarations.

We work exclusively with GMP-compliant manufacturers, ensuring that each order meets stringent quality benchmarks. From the moment the product leaves the production facility to the moment it arrives in your lab or compounding pharmacy, we provide full traceability, transparent sourcing, and unwavering product integrity.

We also understand the UAE market. Our logistics team ensures fast, temperaturecontrolled delivery directly to the Emirates, navigating regulatory requirements and customs processes with precision. Whether you’re sourcing for clinical research, smallscale compounding, or commercial formulation, our team ensures timely, hassle-free access to the materials you need.

And perhaps most importantly—we offer competitive pricing with no compromise on quality. With flexible, volume-based pricing structures, MedicaPharma serves a wide range of veterinary operations, from boutique compounders to large-scale producers.

Tailored for Veterinary Compounding

GS-441524 requires careful formulation by licensed professionals. In the UAE, this often means working with compounding pharmacies and veterinary pharmaceutical labs to develop:

• Oral suspensions or solutions for easy administration at home
• Injectable formulations for acute FIP intervention
• Capsules or tablets for maintenance or follow-up therapy

MedicaPharma supports this process by ensuring you start with a raw ingredient that is chemically stable, reliably pure, and fully documented. Our technical support team is also available to assist with documentation, formulation advice, or quality assurance queries.

A Strategic Partner for UAE Veterinary Pharma

More than just a supplier, MedicaPharma is a trusted partner to veterinary innovators throughout the UAE and beyond. We’ve earned that trust by consistently delivering:

• Top-tier active ingredients produced in GMP facilities
• End-to-end regulatory support and traceability
• Responsive, knowledgeable customer service
• Reliable, secure international shipping
• Pricing structures that suit both development and commercial needs

When you choose MedicaPharma, you’re not only securing the right product—you’re securing peace of mind. You gain access to a global network of pharmaceutical expertise, a logistics infrastructure that works, and a supplier that understands your responsibility to patients—both human and animal.

Secure Your Supply of GS-441524 Today

The opportunity to make a meaningful impact on feline health in the UAE has never been greater. GS-441524 is opening new doors in the treatment of FIP, and your ability to act depends on having the right API partner.

MedicaPharma stands ready to meet your needs—with reliable supply, unmatched quality, and expert support every step of the way.

Request your GS-441524 quote today
Let’s build better veterinary treatments—starting with the right raw materials.

Medicapharma’s products and services are exclusively available to licensed companies and professionals. We do not sell to individuals or private consumers.